ask="100.00"
ask_size="200"
average_daily_volume="462472"
bid="55.00"
bid_size="9900"
book_value="11.49"
change="-1.30"
change_from_200_day_moving_average="6.01"
change_from_50_day_moving_average="3.72"
change_from_52_week_high="-9.89"
change_From_52_week_low="30.36"
change_in_percent="-1.66%"
close="76.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.07"
eps_estimate_next_quarter="-1.77"
eps_estimate_next_year="-6.40"
ex_dividend_date="N/A"
float_shares="38556000"
high="78.47"
high_52_weeks="86.77"
last_trade_date="2/23/2017"
last_trade_price="76.88"
last_trade_size="16207"
last_trade_time="4:00pm"
low="75.03"
low_52_weeks="46.52"
market_capitalization="3.21B"
moving_average_200_day="70.87"
moving_average_50_day="73.16"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="94.50"
open="78.29"
pe_ratio="N/A"
peg_ratio="-0.37"
percent_change_from_200_day_moving_average="+8.48%"
percent_change_from_50_day_moving_average="+5.09%"
percent_change_from_52_week_high="-11.40%"
percent_change_from_52_week_low="+65.26%"
previous_close="78.18"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.80"
price_per_sales="24527.36"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="468934"
weeks_range_52="46.52 - 86.77"
